Behavioral Sensitization and M1 Muscarinic Acetylcholine Receptor mRNA Expression in Methamphetamine-Administered Mice |
Kim, Kyung-In
(Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy)
Cho, Jae-Han (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) Park, Hyun-Jung (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) Lee, Seok-Yong (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) Jang, Choon-Gon (Department of Pharmacology, College of Pharmacy, Sungkyunkwan Univeristy) |
1 | Buckley N. J., Bonner T. I., Buckley C. M. and Brann M. R. (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-Kl cells. Mol Phannacol. 35, 469-476. |
2 | Bymaster F. P, Shannon H. E., Rasmussen K., DeLapp N. W., Ward J. S., Calligaro D.O., Mitch C. H., Whitesitt C., Ludvigsen T. S., Sheardown M., Swedberg M., Rasmussen T., Olesen P. H., Jeppesen L., Sauerberg P. and Fink-Jensen A. (1999) Potential role of muscarinic receptors in schizophrenia. Life Sci. 64, 527-534 DOI ScienceOn |
3 | Caulfield M. P (1993) Muscarinic receptors-characterization, coupling and function. Pharmacol Ther. 58, 319-379 DOI ScienceOn |
4 | Kalivas P. W., Sorg B. A. and Hooks M. S. (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol. 4, 315-334 |
5 | Kitanaka J., Kitanaka N. and Takemura M. (2003) Chronic methamphetamine administration reduces histamine-stimulated phosphoinositide hydrolysis in mouse frontal cortex. Biochem Biophys Res Commun. 300(4), 932-937 DOI ScienceOn |
6 | Kitayama S. and Dohi T. (1996) Cellular and molecular aspects of monoamine neurotransmitter transporters. Jpn J. Pharmacol. 72, 195-208 |
7 | Bonner T. I., Buckley N. J., Young A. C. and Brann M. R. (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science. 237, 527-532 DOI |
8 | Buchanan R. W., Kirkpatrick B., Heinrichs D. W. and Carpenter W. T. (1990) Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 147, 290-294 |
9 | Buckley N. J., Bonner T. I. and Brann M. R (1988) Localization of a family of muscarinic receptor mRNA in rat brain. J Neurosci. 8, 4646-4652 |
10 | Piazza P. V., Deminiere J. M., Ie Moal M. and Simon H. (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine selfadministration. Brain Res. 514(1),22-6 DOI ScienceOn |
11 | Post R. M. and Weiss S. R. B. (1988) Sensitization and kindling: implications for the evolution of psychiatric symptomatology. In: Kalivas, P. W., Barnes, C. D. (Eds.), Sensitization in the Nervous System. Telford Press, Caldwell, 257-292 |
12 | Caulfield M. P. and Birdsall N. J. (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Phannacol Rev. 50(2), 279-290 |
13 | Di Chiara G., Morelli M. and Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/ NMDA interactions. Trends Neurosci. 17, 228-233 DOI ScienceOn |
14 | Drje F., Wess J., Lambrecht G., Tacke R., Mutschler E. and Brann M. (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol Exp Ther. 256, 727-733 |
15 | Fleckenstein A. E., Gibb J. W. and Hanson G. R. (2000) Differential effects of stimulants on monoaminergic transporters:pharmacological conse-quences and implications for neurotoxicity. Eur J. Phannacol. 406, 1-13 DOI ScienceOn |
16 | Fornari R V., Moreira K. M. and Oliveira M. G. (2000) Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn Mem. 7(5), 287-292 DOI ScienceOn |
17 | Gerber D. J., Sotnikova T. D., Gainetdinov R. R., Huang S. Y., Caron M. G. and Tonegawa S. (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U.S.A 98(26),15312-15317 DOI ScienceOn |
18 | Goto Y. and O'Donnell P. (2001) Network synchrony in the nucleus accumbens in vivo. J. Neuroici. 21, 4498-4504 |
19 | Lee E. H. and Tsai M. J. (1989) The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropinreleasing factor in mice. Behav Neural BioI. 51(3), 412-423 DOI ScienceOn |
20 | Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-253 DOI ScienceOn |
21 | Levey A. I., Kitt C. A., Simonds W. F., Price D. L. and Brann M. R. (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11, 3218-3226 |
22 | Maeda A., Kubo T., Mishina M. and Numa S. (1988) Tissue distribution of mRNA encoding muscarinic acetylcholine receptor subtypes. FEBS Lett. 239, 339-342. DOI ScienceOn |
23 | Mark G. P., Hajnal A., Kinney A. E. and Keys A. S. (1999) Selfadministration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychophannacology (Berl). 143(1), 47-53 DOI |
24 | Nathanson N. M. (1987) Molecular properties of the muscarinic acetylcholine receptor. Annu Rev Neurosci. 10, 195-236 DOI ScienceOn |
25 | Nestby P., Vanderschuren L. J., De Vries T. J., Hogenboom F., Wardeh G., Mulder A. H. and Schoffelmeer A. N. (1997) Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychophannacology (Bert). 133(1),69-76 DOI |
26 | Peralta E. G., Ashkenazi A., Winslow J. A. W, Smith D. H., Ramachandran J. and Capon D. J. (1987) Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6, 3923-3929 |
27 | Wess J. (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol. 10, 69-99 DOI ScienceOn |
28 | Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev. 18, 247-291 DOI ScienceOn |
29 | Wise R. A. (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci. 19, 319-340 DOI ScienceOn |
30 | Robinson T. E. and Becker J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration; A review and evaluation of animal models of amphetamine psychosis. Brain Res Rev. 11, 157-198 DOI ScienceOn |
31 | Robinson T. E., Browman K. E., Crombag H. S. and Badiani A. (1998) Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehav Rev. 22, 347-354 DOI ScienceOn |
32 | Seiden L. S., Sabol K. E. and Ricaurte G. A. (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol. 32, 639-677 |
33 | Sousa F. C., Gomes P. B., Noronha E. C., Macedo D. S., Vasconcelos S. M., Fonteles M. M. and Viana G. S. (2001) Effects of dopaminergic and cholinergic interactions on rat behavior. Life Sci. 69(20), 2419-2428 DOI ScienceOn |
34 | Uhl G., Lin Z., Metzger T. and Dar D. E. (1998) Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development. In : Amara SG,editor. Methods in enzymology. Academic Press 296, 456-465 DOI |
35 | Vilaro M. T., Palacios J. M. and Mengod G. (1994) Multiplicity of muscarinic autoreceptor subtypes? Comparison of the distribution of cholinergic cells and cells containing mRNA for five subtypes of muscarinic receptors in the rat brain. Mol. Brain Res. 21, 30-46 DOI ScienceOn |
36 | Yui K. and Miura T. (1996) Behavioral responses induced by repeated treatment with methamphetamine alone and in combination with scopolamine in rats. Neuropsychobiology. 33(1), 21-7 DOI |
37 | Wang H., Lipfert L., Malbon C. C. and Bahouth S. (1989) Sitedirected anti-peptide antibodies define the topography of the beta-adrenergic receptor. J Biol Chem. 264, 14424-14431 |
38 | Wolf M. E., Dahlin S. L., Hu X. T., Xue C. J. and White K. (1995) Effects of lesions of prefrontal cortex, amygdale, or fornix on behavioral sensitization to amphetamine: Comparison with N-methy1-D-aspartate antagonists. Neurosci. 69,417-439 DOI ScienceOn |
39 | Wortley K. E., Hughes Z. A., Heal D. J. and Stanford S. C. (1999) Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by a2-adrenoceptors. Br J Pharm. 127, 1860-1866 DOI ScienceOn |